Ming Fu - Shandong Weigao Independent Non-Executive Director
SHWGF Stock | USD 0.96 0.00 0.00% |
Director
Ms. Fu Ming Zhong is Independent NonExecutive Director of Shandong Weigao Group Medical Polymer Company Limited. She is the senior economist and associate chief pharmacist and has over 40 years of working experience, particular in the area of management experience in the pharmaceutical and healthcare products industry. Mrs. Fu obtained a masters degree in engineering from the Harbin Institute of Technology in March 1992. Mrs. Fu was previously a deputy workshop director, the office head and the vice factory manager of The Third Harbin Pharmaceutical Factory from June 1972 to March 1999. Mrs. Fu was a director of Harbin City Pharmaceutical Group and the general manager of Harbin Pharmaceutical Company Limited from March 1992 to December 1997. She was also a deputy general manager of China Medicines Group from December 1997 to January 1999 and she was a director of China Medicines Group Corporation from January 1999 to July 2009 respectively. Mrs. Fu was the executive deputy general manager of China National Pharmaceutical industry Corporation from January 1999 to January 2001. Ms. Fu was the chairman of National Medicines Company Limited from February 2001 to April 2008. Mrs. Fu was a director of Shenzhen Accord Pharmaceutical Company Ltd. since April 2008 and was the chairman from April 2008 to December 2008. Ms. Fu has also been a director of Sinopharm Industrial Investment Co., Ltd. from July 2008 to December 2010. Mrs. Fu was the general manager, duty chairman and director of Sinopharm Group Co. Ltd. during the period from February 2006 to December 2009, and December 2009 to January 2011 respectively. Mrs. Fu is currently the chairman of China Association of Pharmaceutical Commerce and she joined the Company in October 2011. since 2011.
Age | 66 |
Tenure | 13 years |
Phone | 86 63 1562 1999 |
Web | https://www.weigaogroup.com |
Shandong Weigao Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1276 %, meaning that it generated $0.1276 on every $100 dollars invested by stockholders. Shandong Weigao's management efficiency ratios could be used to measure how well Shandong Weigao manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Margaret Whitman | Procter Gamble | 64 | |
Andrew Rubin | JD Sports Fashion | 52 | |
James McNerney | Procter Gamble | 65 | |
Patricia Woertz | Procter Gamble | 67 | |
Gary Sullivan | Delek Logistics Partners | 67 | |
Heather Jackson | JD Sports Fashion | 51 | |
Shangning Qian | Yuexiu Transport Infrastructure | 51 | |
Susan DesmondHellmann | Procter Gamble | 57 | |
Francis DAndrea | Delek Logistics Partners | 66 | |
Hon Lau | Yuexiu Transport Infrastructure | 67 | |
Amy Chang | Procter Gamble | 44 | |
John Chevalier | Procter Gamble | N/A | |
Francis Blake | Procter Gamble | 70 | |
Ernesto Zedillo | Procter Gamble | 62 | |
Lee Weldon | Natural Alternatives Internatio | 78 | |
Mark Cox | Delek Logistics Partners | 56 | |
Assaf Ginzburg | Delek Logistics Partners | 43 | |
Eric Gadd | Delek Logistics Partners | 65 | |
Loudon Owen | Academy Sports OutdoorsInc | N/A | |
Joseph Jimenez | Procter Gamble | 60 | |
Ronald Haddock | Delek Logistics Partners | 81 |
Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0604 |
Shandong Weigao Group Leadership Team
Elected by the shareholders, the Shandong Weigao's board of directors comprises two types of representatives: Shandong Weigao inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shandong. The board's role is to monitor Shandong Weigao's management team and ensure that shareholders' interests are well served. Shandong Weigao's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shandong Weigao's outside directors are responsible for providing unbiased perspectives on the board's policies.
Junqiang Lu, Ex Director | ||
Jia Li, Independent Non-Executive Director | ||
Miu Wong, Company Secretary | ||
Hong Ju, Vice-General Manager of the Production and Supply Chain | ||
Hua Zhang, Vice Chairman, General Manager, Compliance Officer and Chairman of Corporate Governance Committee | ||
Shu Zhou, Non-Executive Director | ||
Jian Gong, Executive Director | ||
Rinan Cong, CEO Director | ||
Yi Wang, Deputy General Manager of General Affairs and Executive Director | ||
Ming Fu, Independent Non-Executive Director | ||
Jin Cui, CFO | ||
Jinxia Wang, Independent Non-Executive Director | ||
Jin Wang, Independent Non-Executive Director | ||
Shili Ni, Ex Director | ||
Xiu Song, Head - Sales Department | ||
Wai Lo, Independent Non-Executive Director | ||
Yuk Chan, Head - Business Development & Investor Relations | ||
Xue Chen, Non-Executive Chairman of the Board | ||
Lie Xia, Executive Director | ||
De Zhou, Deputy General Manager - Blood Transfusion Division | ||
Xue Wu, Chief Officer | ||
Jing Long, Vice-General Manager of Marketing Management |
Shandong Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Shandong Weigao a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0604 | |||
Profit Margin | 0.18 % | |||
Operating Margin | 0.22 % | |||
Current Valuation | 6.24 B | |||
Shares Outstanding | 4.52 B | |||
Shares Owned By Insiders | 46.39 % | |||
Shares Owned By Institutions | 24.74 % | |||
Price To Earning | 20.29 X | |||
Price To Book | 2.20 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shandong Weigao Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Shandong Weigao Group information on this page should be used as a complementary analysis to other Shandong Weigao's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Shandong Pink Sheet analysis
When running Shandong Weigao's price analysis, check to measure Shandong Weigao's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Weigao is operating at the current time. Most of Shandong Weigao's value examination focuses on studying past and present price action to predict the probability of Shandong Weigao's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Weigao's price. Additionally, you may evaluate how the addition of Shandong Weigao to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |